Clinical Trial Update: COVID-19 Booster and IIV Schedule in Immunocompromised Hosts [Phase 2]

View source ↗

Summary

Phase 2 clinical trial from McGill University Health Centre evaluating a COVID-19 booster and influenza vaccine schedule in immunocompromised hosts. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Inflammatory Bowel Disease
• Rheumatoid Arthritis
• Solid Organ Transplantation
• Systemic Lupus Erythematosus

Drugs mentioned

• COVID-19 vaccine (COVID-19 vaccine)
• Influenza vaccine (influenza vaccine)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: COVID 19, Influenza | Phase 2 | Status: RECRUITING